Our Chair of Trustees, John Wilkinson shares how important volunteering is for him and for the cause as part of Trustees Week 2022.

The board and team at GMDN are delighted to welcome Deniz Bruce as our new Chief Executive Officer. Read more about this next chapter for The GMDN Agency...

In November, we are celebrating the 20 year anniversary of our first digital copy of the GMDN. The GMDN has grown incredibly in this time and is now used globally by more than 150 countries.

The 12th annual UDI Conference 'UDI Beyond Borders, Harnessing Your Data for Medical Device Identification' is the industry gathering for medical device manufacturers, distributors, GPO’s and hospital systems to work through new and anticipated global UDI-related policies.

The National Institute of Surveillance of Medicines and Food (INVIMA) of Colombia has announced its new information system will use GMDN. We have been supporting Colombia in this implementation.

The Unique Device Identifier (UDI) is a number allocated to a product label. It is used to identify the manufacturer and other important product safety information. Read more about the benefits that UDI supports....

The GMDN has been updated to include Brazilian Portuguese translations. This will help to improve accuracy of assignment and drive forward the greater use of GMDN in Brazil.

Detailed considerations for implementing the proposed Australian medical device UDI regulatory framework: A third UDI consultation paper from the TGA (Australian Therapeutic Good Administration)

Global harmonisation and patient safety was taken into consideration during the consultation. Read more about the report recommending the use of GMDN in the UK.

After 12 years with the GMDN Agency, our CEO Mark Wasmuth has chosen to retire. The exact timing of Mark’s retirement is likely to be dependent upon the appointment of his successor.